Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases

Clinical Immunology and Immunopathology

Volumn 79, Issue 3, 1996, Pages 244-251

  Shahar, Iris ^a   Fireman, Elizabeth ^a   Topilsky, Marcel ^a   Grief, Joel ^a   Kivity, Shmuel ^a   Spirer, Zvi ^a   Ben Efraim, Shlomo ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS MACROPHAGE; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 0029975447     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0075     Document Type: Article

References (23)

1. Daniele, R. P., Immunology of sarcoidosis. Semin. Respir. Med. 12, 204-214, 1991.
2. Hunninghake, G. W., Garrett, K. C., Rickerson, H. B., Fantone, J. C., Ward, P. A., and Rennard, S. I., Pathogenesis of the granulomatous lung disease. Am. Rev. Respir. Dis. 130, 476-496, 1984.
3. Thomas, P. D., and Hunninghake, C. W., Current concepts of the pathogenesis of sarcoidosis. Am. Rev. Respir. Dis. 135, 747-760, 1987.
4. Kraus, R., Steinberg, F., Rehn, B., Bruch, J., and Streffer, C., Radiation-induced changes in lung tissue and development of fibrosis determined by quantitative morphometric methods. J. Cancer Res. Clin. Oncol. 117, 27-32, 1991.
5. Lordi, G. M., and Reichman, L. B., Pulmonary complications of asbestos exposure. Am. Fam. Physician. 48, 1471-1477, 1993.
6. Sheppard, M. N., and Harrison, N. K., Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis. Thorax 47, 1064-1074, 1992.
7. Tierney, L. M., Idiopathic pulmonary fibrosis. Semin. Respir. Med. 12, 229-237, 1991.
8. Rennard, S. I., Hunninghake, G. W., Gadek, J. E., Fales, H., and Crystal, R. G., Production of fibronectin by human alveolar macrophages: Mechanism for recruitment of fibroblasts to sites of tissue injury in interstitial lung disease. Proc. Natl. Acad. Sci. USA 78, 7147-7151, 1981.
9. Rom, W. N., Basset, P., Fells, G. A., Nukiwa, T., Trapnell, B. C., and Crystal, R. G., Alveolar macrophages release an insulin-like growth factor 1-type molecule. J. Clin. Invest. 82, 1685-1693, 1988.
10. Raghu, G., and Kavanagh, T., The human lung fibroblast: a multifaceted target and effector cell. In "Interstitial Pulmonary Diseases: Selected Topics" (M. Selman Lama and R. Barrios, Eds.), pp. 1-34, CRC Press, Boca Raton, FL, 1991.
11. Elias J., Reynolds, M. M., Kotloff, R. M., and Kern, J. A., Fibroblast Interleukin-1 beta synthesis: Stimulation by recombinant interleukin-1 and tumor necrosis factor. Proc. Natl. Acad. Sci. USA 86, 6171-5617, 1989.
12. Rose-John, S., Hipp, E., Lenz, D., Legres, L., Korr, H., Hirano, T., Kishimoto, T., and Heinrich, P., Structural and functional studies on the human interleukin-6 receptor. J. Biol. Chem. 266, 3841-3846, 1991.
13. Denis, M., Interleukin-6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J. Leukocyte Biol. 52, 197-201, 1992.
14. 2 production and suppressor activity of alveolar macrophages from patients with interstitial lung diseases. Immunol. Lett. 181, 159-166, 1988.
15. Fireman, E., Ben Efraim, S., Messer, G., Dabush, S., Greif, J., and Topilsky, M., Cell-free supernatants of sarcoid alveolar macrophages suppress proliferation of sarcoid alveolar fibroblasts. Clin Immunol. Immunopathol. 59, 368-378, 1991.
16. Sahashi, K., Ina, Y., Takada, K., Sato, T., Yamamoto, M., and Morishita, M., Significance of interleukin 6 in patients with sarcoidosis. Chest 106, 156-160, 1994.
17. Steffen, M, Petersen, J., Oldigs, M., Karmeier, A., Magnussen, H, Thiele, H. G., and Raedler, A., Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. J. Allergy Clin. Immunol. 91, 939-949, 1993.
18. Fireman, E., Aderka, D., Ben Efraim, S., Greif, J., Wallach, D., and Topilsky, M., Suppressive effect of TNFα and IL-1 on alveolar fibroblasts proliferation in sarcoidosis. Mediat. Inflamm. 1, 319-322, 1992.
19. Fries, K. M., Felch, M. E., and Phipps, R. P., Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets. Am. J. Respir. Cell Mol. Biol. 11, 552-560, 1994.
20. Breen, E., Falco, V. M., Absher, M., and Cutroneo, K. R., Subpopulations of rat lung fibroblasts with different amounts of type I and type III collagen mRNAs. J. Biol. Chem. 265, 6286-6290, 1990.
21. Vyalov, S. L., Gabbiani, G., and Kapanci, Y., Rat alveolar myofibroblasts acquire α-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 143, 1754-1765, 1993.
22. Skalli, O., Schurch, W., Seemayer, T., Lagace, R., Montandon, D., Pittet, B., and Gabbiani, G., Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab. Invest. 60, 275-285, 1989.
23. Sappino, A. P., Schurch, W., and Gabbiani, G., Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab. Invest. 63, 144-161, 1990.